Overview

Therapeutic Equivalence of Fluorouracil Cream, 5% Compared With EFUDEX® in the Treatment of Actinic Keratosis

Status:
Not yet recruiting

Trial end date:
2022-05-31

Target enrollment:

Participant gender:

Summary

Fluorouracil is recommended for the topical treatment of multiple actinic or solar keratoses. In the 5% strength, it is also useful in the treatment of superficial basal cell carcinomas when conventional methods are impractical, such as with multiple lesions or difficult treatment sites.

Phase:

Phase 3

Details

Lead Sponsor:

Encube Ethicals Pvt. Ltd.

Collaborator:

CBCC Global Research

Treatments:

Fluorouracil